Markus’ previous experience in Medicines for Europe spans the range of priority topics for our sector, including the EU pharmaceutical legislation, Critical Medicines Act, the…
The letter, signed by CEOs and senior executives from across the European off-patent medicines sector, focuses on the need to: Accelerate the adoption of the…
Commitment to Health Security Public health is a fundamental right. As EU Health Ministries approach the final stages of negotiations on the future of Europe’s…
Among the awarded projects by Polpharma are: Development and advancement of inhaled complex generic drugs for the treatment of respiratory diseases such as COPD and…
Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.
By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.